Skip to main content
Clinical Trials/NL-OMON32447
NL-OMON32447
Withdrawn
Phase 2

Early mobilization of mechanically ventilated critically ill patients aimed at optimizing recovery and reduce stay on the Thorax Intensive Care Unit: Thekla as intervention - Thekla on the TIC

Medisch Spectrum Twente0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Spectrum Twente
Enrollment
30
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Cardiovascular criteria: resting heart rate \<120 beats per minute, blood pressure \<20% variability recently and normal ECG.
  • Respiratory criteria: SpO2 \>90% and \<4% recent decrease in SpO2, respiratory rate \<35 breaths per minute and mechanical ventilation needs to be able to be maintained during treatment.
  • Additional criteria: haemoglobin stable and \>4\.8 gramms/dL, platelet count stable and \>50,000 cells/mm3, white cell count 4,300 \- 10,800 cells/mm3, body temperature \<38°C, blood glucose level 3\.5 \-12 mmol/L, patient must not experience excessive pain/ fatigue/ shortness of breath and the emotional status must be acceptable.

Exclusion Criteria

  • Patients receiving other interventions than regular mobilization therapy (considered to be; active, active\-assisted and passive range of motion exercises for all limbs, breathing exercises, sputum clearance and transfers performed are supine to sit, from bed to chair and pre\-walking exercises) provided by nursing staff and/or physiotherapists, \<18 years of age, enrollment in another trial, evidence of postoperative myocardial infarction or arrhythmia, orthopedic contraindications, recent split skin graft/ flap to lower limbs or trunk, \>150 kg of weight, Intra Aortic Balloon Pump, Continuous Veno \- Venous Hemofiltration in groin, arterial line in groin, deep venous thrombosis, pulmonary embolism, neurological contraindications or no Dutch language proficiency.

Outcomes

Primary Outcomes

Not specified

Similar Trials